Help for Menopausal Patients with Lupus?
Authors: Evelyn V. Hess
Journal: Annals of Internal Medicine (2005)

Editorials21 June 2005Help for Menopausal Patients with Lupus?Evelyn V. Hess, MDEvelyn V. Hess, MDFrom the University of Cincinnati Cincinnati, OH 45267-0563.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Systemic lupus erythematosus (SLE) is a worldwide disease occurring predominantly in younger women, although the number of affected men is increasing. More middle-aged and older patients are also living with lupus because diagnoses are made later in life and patients are surviving longer. In fact, the mortality rate has changed dramatically. In the 1950s and early 1960s, 90% of patients with lupus were dead within 10 years of disease onset. Today, 90% of those affected are alive and doing well 10 years after diagnosis (1). Successful management has allowed many of the estimated 1 million to 1.5 million patients with ...References1. Gladman DD. Epidemiology of SLE.. In: Lahita RG, eds. Systemic Lupus Erythematosus. 4th ed. New York: J Wiley; 2004. Google Scholar2. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142:953-62. LinkGoogle Scholar3. Primer on the Rheumatic Diseases. 12th ed. Atlanta: Arthritis Foundation; 2001. Google Scholar4. Alarcón GS, McGwin G, Roseman JM, Uribe A, Fessler BJ, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. Arthritis Rheum. 2004;51:609-15. [PMID: 15334435] CrossrefMedlineGoogle Scholar5. Lahita RG. Gender and age in lupus.. In: Lahita RG, eds. Systemic Lupus Erythematosus. 4th ed. New York: J Wiley; 2004. Google Scholar Author, Article, and Disclosure InformationAffiliations: From the University of Cincinnati Cincinnati, OH 45267-0563.Acknowledgments: The author thanks Drs. Anne-Barbara Mongey, Yolanda Farhey, and Margery Gass for their helpful comments.Disclosures: None disclosed.Corresponding Author: Evelyn V. Hess, MD, University of Cincinnati, 231 Albert Sabin Way #7464, Cincinnati, OH 45267-0563; e-mail, [email protected]uc.edu. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial Jill P. Buyon , Michelle A. Petri , Mimi Y. Kim , Kenneth C. Kalunian , Jennifer Grossman , Bevra H. Hahn , Joan T. Merrill , Lisa Sammaritano , Michael Lockshin , Graciela S. Alarcón , Susan Manzi , H. Michael Belmont , Anca D. Askanase , Lisa Sigler , Mary Anne Dooley , Joan Von Feldt , W. Joseph McCune , Alan Friedman , Jane Wachs , Mary Cronin , Michelene Hearth-Holmes , Mark Tan , and Frederick Licciardi The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial Jill P. Buyon , Michelle A. Petri , Mimi Y. Kim , Kenneth C. Kalunian , Jennifer Grossman , Bevra H. Hahn , Joan T. Merrill , Lisa Sammaritano , Michael Lockshin , Graciela S. Alarcón , Susan Manzi , H. Michael Belmont , Anca D. Askanase , Lisa Sigler , Mary Anne Dooley , Joan Von Feldt , W. Joseph McCune , Alan Friedman , Jane Wachs , Mary Cronin , Michelene Hearth-Holmes , Mark Tan , and Frederick Licciardi Metrics Cited ByEfficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: A randomized, double-blind, controlled trialContracepción en el lupus eritematoso sistémicoSystemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA L II)The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial 21 June 2005Volume 142, Issue 12_Part_1Page: 1014-1015KeywordsEstrogensFollicle-stimulating hormoneHormonal therapyHormone replacement therapyHormonesLupus erythematosusMenopauseRenal diseasesStrokeSystemic lupus erythematosus ePublished: 21 June 2005 Issue Published: 21 June 2005 CopyrightCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...